Literature DB >> 6595193

Peripheral autoregulation of thyroxine to triiodothyronine conversion in man.

J T Nicoloff, S M Lum, C A Spencer, R Morris.   

Abstract

This study describes the existence of a peripheral tissue mechanism for maintaining serum T3 concentrations in states of T4 deficiency or excess in man. Serum T3 and T4 levels were determined in 242 primary hypothyroid subjects who had been maintained on varying doses of oral T4 therapy. Subjects treated with sub-maintenance T4 doses were supplemented by additional oral T3 therapy to maintain eumetabolic status as assessed by suppression of serum TSH values. This T3 supplementation was withdrawn 4-5 days prior to study in order to obviate any influence on serum T3 indices. Serum total T3/T4 ratio values in this study population were observed to progressively decline fivefold in a curvilinear manner as serum T4 concentrations rose from less than 0.5 to 20 micrograms/dl (total serum T3/T4 ratio fell from approximately 50 to 10, ng T3/ng T4 X 10(3)). This phenomenon is presumably the result of an altered T4 to T3 conversion by peripheral tissue 5'-deiodinase systems. A similar alteration of T4 to rT3 conversion with changing serum T4 levels does not appear to occur since serum rT3/T4 ratios did not vary in a separate study population over a serum T4 concentration span from 4-16 micrograms/dl. The mechanism by which this autoregulatory control of T4 to T3 conversion occurs is unknown. However, it would appear physiologically to complement the pituitary-thyroid autoregulatory system by acting to defend and maintain serum T3 concentrations in states of T4 deficiency and excess.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6595193

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN: 0170-5903


  13 in total

1.  A Longitudinal Study of Thyroid Markers Across Pregnancy and the Risk of Gestational Diabetes.

Authors:  Shristi Rawal; Michael Y Tsai; Stefanie N Hinkle; Yeyi Zhu; Wei Bao; Yuan Lin; Pranati Panuganti; Paul S Albert; Ronald C W Ma; Cuilin Zhang
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 3.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

4.  Thyroxine replacement treatment: clinical judgment or biochemical control?

Authors:  A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

5.  New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.

Authors:  William L Green
Journal:  AAPS J       Date:  2005-03-30       Impact factor: 4.009

6.  Thyrotropin Levels Are Associated with Cardiometabolic Risk Factors in Euthyroid Adolescents.

Authors:  Trang N Le; Francesco S Celi; Edmond P Wickham
Journal:  Thyroid       Date:  2016-09-27       Impact factor: 6.568

7.  [Acute factitious hyperthyroidism--moderate clinical symptoms in 3 cases under beta-blocker treatment].

Authors:  F S Keck; U Loos; L Duntas; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1986-04-01

Review 8.  Defending plasma T3 is a biological priority.

Authors:  Sherine M Abdalla; Antonio C Bianco
Journal:  Clin Endocrinol (Oxf)       Date:  2014-08-07       Impact factor: 3.478

9.  Thr92Ala polymorphism of human type 2 deiodinase gene (hD2) affects the development of Graves' disease, treatment efficiency, and rate of remission.

Authors:  Babenko Alina; Popkova Daria; Freylihman Olga; Solncev Vladislav; Kostareva Anna; Grineva Elena
Journal:  Clin Dev Immunol       Date:  2012-11-12

Review 10.  Deiodinases and the Metabolic Code for Thyroid Hormone Action.

Authors:  Samuel C Russo; Federico Salas-Lucia; Antonio C Bianco
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.